Literature DB >> 29922894

Resuscitative endovascular balloon occlusion of the aorta for non-traumatic intra-abdominal hemorrhage.

Melanie R Hoehn1, Natasha Z Hansraj2, Amelia M Pasley1, Megan Brenner1, Samantha R Cox1, Jason D Pasley1, Jose J Diaz1, Thomas Scalea1.   

Abstract

BACKGROUND: Hemorrhagic shock is the second leading cause of death in blunt trauma and a significant cause of mortality in non-trauma patients. The increased use of resuscitative endovascular balloon occlusion of the aorta (REBOA) as a bridge to definitive control for massive hemorrhage has provided promising results in the trauma population. We describe an extension of this procedure to our hemodynamically unstable non-trauma patients.
METHODS: This is a retrospective review of patients requiring REBOA for end stage non-traumatic abdominal hemorrhage from our tertiary care facility. After excluding patients with trauma, supradiaphragmatic bleed and thoracic/abdominal aortic aneurysms, demographics, etiology of bleed, REBOA placement specifics, complications and outcomes were reviewed.
RESULTS: From August 2013 to August 2016, 11 patients were identified requiring REBOA placement for hemodynamic instability from non-traumatic abdominal hemorrhage. Average patient age was 54.9 (SD 15.2). Sixty-four percent suffered cardiac arrest prior to REBOA, with mean shock index of 1.29. Average time from diagnosis of shock (MAP ≤ 65) or signs of bleeding to placement of REBOA was 177 min. The leading etiologies of hemorrhage were ruptured visceral aneurysm and massive upper gastrointestinal bleed. REBOA was placed by both acute care and vascular surgeons. The procedure was mainly completed in the operating room in 82% of the patients and at the bedside in 18%. One patient expired before operative repair. Definitive surgical control of the source of bleeding was obtained by open surgical approach (n = 6) and combined surgical and endovascular approach (n = 4). In-hospital survival was 64%. There were no local complications related to REBOA placement.
CONCLUSION: Similar to the trauma population, REBOA is an adjunctive technique for proximal control of bleeding as well as resuscitation in end stage non-traumatic intra-abdominal hemorrhage. We propose an algorithmic approach to REBOA use in this population and a larger prospective review is necessary to determine both the timing of REBOA placement and which non-traumatic patients may benefit from this technique. LEVEL OF EVIDENCE: V. STUDY TYPE: Brief report.

Entities:  

Keywords:  Hemorrhagic shock; Non-compressible abdominal hemorrhage; REBOA; Shock

Year:  2018        PMID: 29922894     DOI: 10.1007/s00068-018-0973-0

Source DB:  PubMed          Journal:  Eur J Trauma Emerg Surg        ISSN: 1863-9933            Impact factor:   3.693


  9 in total

1.  When the balloon goes up, blood transfusion goes down: a pilot study of REBOA in placenta accreta spectrum disorders.

Authors:  Yevgeniya J M Ioffe; Sigrid Burruss; Ruofan Yao; Beverly Tse; Alicia Cryer; Kaushik Mukherjee; Linda J Hong
Journal:  Trauma Surg Acute Care Open       Date:  2021-08-13

Review 2.  Fetal and neonatal outcomes following maternal aortic balloon occlusion for hemorrhage in pregnancy: A review of the literature.

Authors:  Christina M Theodorou; Tanya N Rinderknecht; Eugenia Girda; Joseph M Galante; Rachel M Russo
Journal:  J Trauma Acute Care Surg       Date:  2022-01-01       Impact factor: 3.313

3.  Spontaneous rupture of the pancreatic arcade artery caused by neurofibromatosis type 1 successfully treated using emergency transcatheter arterial embolization, partial intra-aortic balloon occlusion, and stent graft placement: a case report and review of the literature.

Authors:  Ryo Morita; Daisuke Abo; Takeshi Soyama; Yuki Yoshino; Toru Yoshikawa; Tasuku Kimura; Kohsuke Kudo
Journal:  CVIR Endovasc       Date:  2020-07-26

4.  Resuscitative endovascular balloon occlusion of the aorta (REBOA): indications: advantages and challenges of implementation in traumatic non-compressible torso hemorrhage.

Authors:  Omar Bekdache; Tiffany Paradis; Yu Bai He Shen; Aly Elbahrawy; Jeremy Grushka; Dan Deckelbaum; Kosar Khwaja; Paola Fata; Tarek Razek; Andrew Beckett
Journal:  Trauma Surg Acute Care Open       Date:  2019-04-15

5.  Does the conventional landmark help to place the tip of REBOA catheter in the optimal position? A non-controlled comparison study.

Authors:  Kento Nakajima; Hayato Taniguchi; Takeru Abe; Keishi Yamaguchi; Tomoki Doi; Ichiro Takeuchi; Naoto Morimura
Journal:  World J Emerg Surg       Date:  2019-07-16       Impact factor: 5.469

6.  Successfully REBOA performance: does medical specialty matter? International data from the ABOTrauma Registry.

Authors:  Peter Hilbert-Carius; David McGreevy; Fikri M Abu-Zidan; Tal M Hörer
Journal:  World J Emerg Surg       Date:  2020-11-23       Impact factor: 5.469

7.  Zone-dependent acute circulatory changes in abdominal organs and extremities after resuscitative balloon occlusion of the aorta (REBOA): an experimental model.

Authors:  Sascha Halvachizadeh; Ladislav Mica; Yannik Kalbas; Miriam Lipiski; Marko Canic; Michel Teuben; Nikola Cesarovic; Zoran Rancic; Paolo Cinelli; Valentin Neuhaus; Hans- Christoph Pape; Roman Pfeifer
Journal:  Eur J Med Res       Date:  2021-01-21       Impact factor: 2.175

8.  Life-threatening gastrointestinal bleeding from splenic artery pseudoaneurysm due to gastric ulcer penetration treated by surgical hemostasis with resuscitative endovascular balloon occlusion of the aorta: A case report.

Authors:  Tomonori Nakata; Yuko Okishio; Kentaro Ueda; Toru Nasu; Shuji Kawashima; Kosei Kunitatsu; Seiya Kato
Journal:  Clin Case Rep       Date:  2022-03-10

9.  Intraoperative REBOA: an analysis of the American Association for the Surgery of Trauma AORTA registry.

Authors:  Michael A Vella; Ryan Peter Dumas; Joseph DuBose; Jonathan Morrison; Thomas Scalea; Laura Moore; Jeanette Podbielski; Kenji Inaba; Alice Piccinini; David S Kauvar; Valorie L Baggenstoss; Chance Spalding; Charles Fox; Ernest E Moore; Jeremy W Cannon
Journal:  Trauma Surg Acute Care Open       Date:  2019-11-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.